BioDyad integrates biomedical discovery with ML program search
BioDyad is a new agentic system that links biomedical evidence and machine learning engineering. It uses two hierarchies—one for scientific discovery and one for program engineering—to guide candidate construction, execution, and validation. The system prioritizes integrating external biomedical knowledge into executable programs across diverse tasks.
Key points
- BioDyad combines biomedical discovery and ML engineering via two hierarchies in Monte Carlo graph search
- Outperformed four agent methods and a baseline on the 76-task **BioXArena** benchmark
- Evaluated with three LLM backends under a two-hour per-task budget
Developed by researchers, BioDyad was evaluated on the 76-task BioXArena benchmark under a two-hour per-task budget. It outperformed four other agent methods and a one-shot baseline across three LLM backends, achieving the highest penalized all-task score and task success rate. The paper, posted on arXiv, highlights its potential to improve coordination between biomedical research and ML workflows.
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Research
All →- Anthropic's Claude begins 'dreaming' to reorganize memory in tests · 1 src
- John Langford quits Microsoft, declares AI Frontiers over · 1 src
- Anthropic releases study on Claude usage in scientific research · 3 src
- MIT and BASF release CheMeleon for low-data molecular prediction · 2 src
- Anthropic tests Claude agents in EVE Online trading and sabotage detection · 1 src
Comments
via GitHub Discussions